The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Trial of Pregabalin for Acute and Chronic Sciatica
Open accessAbstract
BACKGROUND: Sciatica can be disabling, and evidence regarding medical treatments is limited. Pregabalin is effective in the treatment of some types of neuropathic pain. This study examined whether pregabalin may reduce the intensity of sciatica. METHODS: We conducted a randomized, double-blind, placebo-controlled trial of pregabalin in patients with sciatica. Patients were randomly assigned to receive either pregabalin at a dose of 150 mg per day that was adjusted to a maximum dose of 600 mg per day or matching placebo for up to 8 weeks. The primary outcome was the leg-pain intensity score on a 10-point scale (with 0 indicating no pain and 10 the worst possible pain) at week 8; the leg-pain intensity score was also evaluated at week 52, a secondary time point for the primary outcome. Secondary outcomes included the extent of disability, back-pain intensity, and quality-of-life measures at prespecified time points over the course of 1 year. RESULTS: A total of 209 patients underwent randomization, of whom 108 received pregabalin and 101 received placebo; after randomization, 2 patients in the pregabalin group were determined to be ineligible and were excluded from the analyses. At week 8, the mean unadjusted leg-pain intensity score was 3.7 in the pregabalin group and 3.1 in the placebo group (adjusted mean difference, 0.5; 95% confidence interval [CI], -0.2 to 1.2; P=0.19). At week 52, the mean unadjusted leg-pain intensity score was 3.4 in the pregabalin group and 3.0 in the placebo group (adjusted mean difference, 0.3; 95% CI, -0.5 to 1.0; P=0.46). No significant between-group differences were observed with respect to any secondary outcome at either week 8 or week 52. A total of 227 adverse events were reported in the pregabalin group and 124 in the placebo group. Dizziness was more common in the pregabalin group than in the placebo group. CONCLUSIONS: Treatment with pregabalin did not significantly reduce the intensity of leg pain associated with sciatica and did not significantly improve other outcomes, as compared with placebo, over the course of 8 weeks. The incidence of adverse events was significantly higher in the pregabalin group than in the placebo group. (Funded by the National Health and Medical Research Council of Australia; PRECISE Australian and New Zealand Clinical Trials Registry number, ACTRN12613000530729 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Quality of life (QoL) through the SF-12 questionnaire was assessed in one of the pregabalin trials.21 No statistical differences were found at 2, 8, 26 and 52 weeks.”
From A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain (2022) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Serious AE were similar in the pregabalin group and the placebo group21, 27 as well as in patients with one or more AE.27, 28”
From A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain (2022) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“This study focuses specifically on the use of gabapentin and pregabalin for pain associated with acute sciatica since the evidence on their use is limited.”
From A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain (2022) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“Assessment of other potential sources of bias gave a low risk of bias for four studies.20, 21, 30, 31 Three were rated as unclear risk of bias28, 29, 32 and one was rated as high risk of bias27 due to a run-in period, where placebo respondents and pregabalin non-respondents were eliminated.”
From A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain (2022) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“Five were double-blinded21, 27, 28, 29, 32; one was single-blinded30; and two were open label.20, 31”
From A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain (2022) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“In particular as regards pregabalin, three studies compared pregabalin versus placebo21, 27, 29 and one compared limaprost versus pregabalin versus an association of both drugs in a three-arm trial.28”
From A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain (2022) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“Only four studies assessed pregabalin undesirable effects.21, 27, 28, 29”
From A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain (2022) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“To our knowledge regarding their use on sciatica, pain relief only has been reported in one trial comparing gabapentin with placebo20 and in no one of those investigating pregabalin.21”
From A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain (2022) · cites this paper as [21]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Attrition bias was rated as an unclear risk for most of the trials. Three were rated as low risk of bias,21, 27, 31 and two were rated as high risk of bias.29, 32”
From A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain (2022) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
The estimation of a preference-based measure of health from the SF-36.
Brazier, J., Roberts, J., & Deverill, M. (2002) · Journal of Health Economics · doi:10.1016/s0167-6296(01)00130-8 · Cited by 3,164
Pain: a review of three commonly used pain rating scales
Williamson, A., & Hoggart, B. (2005) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2005.01121.x · Cited by 3,083
Freynhagen, R., Baron, R., Gockel, U., & Tölle, T. R. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x132488 · Cited by 2,280
Ostelo, R. W. J. G., Deyo, R. A., Stratford, P., Waddell, G., Croft, P., Von Korff, M., Bouter, L. M., & de Vet, H. C. (2008) · Spine · doi:10.1097/brs.0b013e31815e3a10 · Cited by 2,009
Koes, B. W., van Tulder, M. W., Lin, C. C., Macedo, L. G., McAuley, J. H., & Maher, C. G. (2010) · European Spine Journal · doi:10.1007/s00586-010-1502-y · Cited by 1,301
Self-citationThe Estimation of a Preference-Based Measure of Health From the SF-12
Brazier, J. E., & Roberts, J. (2004) · Medical Care · doi:10.1097/01.mlr.0000135827.18610.0d · Cited by 1,294
Surgery versus Prolonged Conservative Treatment for Sciatica
Peul, W. C., van Houwelingen, H. C., van den Hout, W. B., Brand, R., Eekhof, J. A., Tans, J. T. J., Thomeer, R. T. W. M., & Koes, B. W. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064039 · Cited by 864
Self-citation
Flagged first, then by citations
Research works printed but not linked: 5
- Moore RA, 2009, Cochrane Database Syst Rev, CD007076
- Mangaiarkkarasi A, 2015, J Clin Diagn Res, 9, FF11
- Food and Drug Administration. Statistical review and evaluation: antiepileptic drugs and suicidality. Rockville, MD: Department of Health and Human Services, 2008.
- Ehrlich GE, 2003, Bull World Health Organ, 81, 671
- Bombardier C, 2001, J Rheumatol, 28, 431
Cited by
Sorted by citations
Items 101–200 of 220
Grøvle, L., Hasvik, E., Holst, R., Sætre, A., Brox, J. I., Mathiassen, S., Myhre, K., Holmgard, T. E., & Haugen, A. J. (2024) · Pain · doi:10.1097/j.pain.0000000000003280 · Cited by 9
da Silva, M. L., Fernandes, A. M., da Silva, V. A., Galhardoni, R., Felau, V., Araujo, J. O., Rosí, J., Brock, R. S., Kubota, G. T., Teixeira, M. J., et al. (2023) · Neurophysiologie Clinique · doi:10.1016/j.neucli.2023.102853 · Cited by 9
Bai, X., Batallé, G., Martínez-Martel, I., & Pol, O. (2023) · Antioxidants · doi:10.3390/antiox12061179 · Cited by 9
Williams, J. D., Gingras, M., Dubé, R., Lee, T. C., & McDonald, E. G. (2022) · CMAJ Open · doi:10.9778/cmajo.20210302 · Cited by 9
What Is the Numerical Nature of Pain Relief?
Vigotsky, A. D., Tiwari, S. R., Griffith, J. W., & Apkarian, A. V. (2021) · Frontiers in Pain Research · doi:10.3389/fpain.2021.756680 · Cited by 8
Avoid routinely prescribing medicines for non-specific low back pain
Traeger, A. C., Buchbinder, R., Harris, I. A., Clavisi, O., & Maher, C. G. (2018) · British Journal of Sports Medicine · doi:10.1136/bjsports-2017-098614 · Cited by 8
Self-citationChou, R., Dana, T., & Shetty, K. D. (2020) · doi:10.23970/ahrqepcmethtestingmachinelearning · Cited by 7
Guo, Y.-H., Huang, X.-G., Liao, W., Meng, L., Xu, D., Ye, C., Chen, L., & Hu, T. (2021) · ACS Omega · doi:10.1021/acsomega.1c01866 · Cited by 7
Pagnez, M. A. M., Corrêa, L. A., de Almeida, R. S., Meziat‐Filho, N., Mathieson, S., Ricard, F., & Nogueira, L. A. C. (2019) · Journal of Manipulative and Physiological Therapeutics · doi:10.1016/j.jmpt.2019.03.003 · Cited by 7
Self-citationPrimary Care Physician Characteristics and Low-Value Care Provision in Japan
Miyawaki, A., Mafi, J. N., Abe, K., Klomhaus, A. M., Goto, R., Kitajima, K., Sato, D., & Tsugawa, Y. (2025) · JAMA Health Forum · doi:10.1001/jamahealthforum.2025.1430 · Cited by 6
Non-operative treatment for low back pain: A review of evidence and recommendations
Garg, B., George, J., & Mehta, N. H. (2022) · The National Medical Journal of India · doi:10.25259/nmji_827_20 · Cited by 6
Cheng, E. T. L., Cheik-Hussein, M., Lin, N., Lewin, A. M., McAuley, J. H., & Harris, I. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280593 · Cited by 6
Self-citationBed Rest for Sciatica: A Closer Look at the Evidence
Mattia, F. D., Tejani, S., & Hall, T. M. (2018) · Journal of Orthopaedic and Sports Physical Therapy · doi:10.2519/jospt.2018.0609 · Cited by 6
Tampin, B., Lind, C. R. P., Jacques, A., & Slater, H. (2021) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2021-0058 · Cited by 6
Efficacy and safety of pregabalin in eye pain: A systematic review
Shen, X., Chen, X., He, Y., Xu, H., & Zhu, J. (2023) · Medicine · doi:10.1097/md.0000000000032875 · Cited by 6
Grøvle, L., Hasvik, E., Holst, R., & Haugen, A. J. (2022) · Trials · doi:10.1186/s13063-022-06441-3 · Cited by 6
Hospital admissions for acute low back pain
Needs, C., & Laurent, R. (2019) · Internal Medicine Journal · doi:10.1111/imj.14227 · Cited by 6
Bajracharya, R., & Qato, D. M. (2021) · Journal of Aging and Health · doi:10.1177/0898264320959293 · Cited by 5
Suzuki, H., Kaito, T., Nakashima, H., Takahashi, H., Yamamoto, S., Tabata, S., & Toyoda, H. (2025) · Pain and Therapy · doi:10.1007/s40122-025-00776-w · Cited by 5
Chen, Q., Ma, K., Wang, B., & Chen, Y. Q. (2021) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.11.019 · Cited by 5
Ward, J., Grinstead, A., Kemp, A., Kersten, P., Schmid, A. B., & Ridehalgh, C. (2024) · Drugs · doi:10.1007/s40265-024-02085-6 · Cited by 7
Belavý, D. L., Tagliaferri, S. D., Buntine, P., Saueressig, T., Sadler, K., Ko, C., Miller, C. T., & Owen, P. J. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101193 · Cited by 5
Murape, T., Ainslie, T., Basson, A., & Schmid, A. B. (2022) · South African Journal of Physiotherapy · doi:10.4102/sajp.v78i1.1627 · Cited by 5
Sciatic Neuralgia Caused by May-Thurner Syndrome
Yamamoto, K., Gondo, G., Ogino, H., Watanabe, T., Tanaka, M., Tanaka, S., & Kawasaki, T. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.05.035 · Cited by 5
The optimization of differential diagnosis and treatment of cervical radiculopathy (SHERPA study)
Samartsev, I. N., Живолупов, С. А., Vorobyova, M. N., Сергеевич, П. М., & Nazhmudinov, R. Z. (2020) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202012009137 · Cited by 5
Is Pregabalin Ineffective in Acute or Chronic Sciatica?
Attal, N., & Barrot, M. (2017) · New England Journal of Medicine · doi:10.1056/nejme1701147 · Cited by 5
Pregabalin misuse: the next wave of prescription medication problems
Murnion, B. P., & Conigrave, K. M. (2018) · The Medical Journal of Australia · doi:10.5694/mja2.12056 · Cited by 5
Matsuoka, H., Tagami, K., Ariyoshi, K., Oyamada, S., Kizawa, Y., Inoue, A., & Koyama, A. (2019) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyz002 · Cited by 4
Schwartz, S. M., Barpujari, A., Finnerup, N. B., & Raja, S. N. (2021) · Pain · doi:10.1097/j.pain.0000000000002426 · Cited by 4
Mathieson, S., Collie, A., Maher, C. G., Shaheed, C. A., Xia, T., Gilbert, S. E., Ferreira, G. E., & Donato, M. F. D. (2024) · Occupational and Environmental Medicine · doi:10.1136/oemed-2023-109369 · Cited by 4
Self-citationNikles, J., Keijzers, G., Mitchell, G. K., Schug, S. A., Ware, R. S., McLean, S. A., Connelly, L. B., Gibson, S. J., Farrell, S. F., & Sterling, M. M. (2018) · Trials · doi:10.1186/s13063-018-2450-9 · Cited by 4
Lassere, M. N., Johnson, K. R., Thom, J. M., Pickard, G., & Smerdely, P. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020435 · Cited by 4
A qualitative exploration of patient experiences of medication for sciatica
Reddington, M., Baxter, S. K., & Walters, S. J. (2021) · Musculoskeletal Science and Practice · doi:10.1016/j.msksp.2021.102419 · Cited by 4
Jaeger, M. D., Goudman, L., Schuerbeek, P. V., Mey, J. D., Keymeulen, B., Brouns, R., & Moens, M. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0460-y · Cited by 4
Liu, C., Shaheed, C. A., McLachlan, A. J., Latimer, J., Li, Q., Buchbinder, R., Day, R. O., Maher, C. G., Richards, B. L., Oliveira, J. S., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040559 · Cited by 4
Self-citationSurgery versus Conservative Care for Persistent Sciatica
Figueiredo, E. G., Rabelo, N. N., & Teixeira, M. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2010782 · Cited by 4
Zheng, Y.-N., Zheng, Y.-L., Liu, H., Ren, S., Guo, S.-J., Sun, T., Guan, J.-Y., Shi, Y.-Q., Chen, P., & Wang, X. (2025) · The Journal of Headache and Pain · doi:10.1186/s10194-025-02176-z · Cited by 3
Aldera, M., Alturkistany, A. Q., Rayes, H. A., Gabriel Rada, G., Alsulaimany, H. H., Alsobayel, H., Alghamdi, K., Awwad, W. M., Alyamani, O. A., Bedaiwi, M. K., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020528 · Cited by 3
Yang, W., Liu, H., Liu, M., Liu, L., Liu, F., Dong, Z., & Li, X. (2026) · Journal of Pain Research · doi:10.2147/jpr.s584489 · Cited by 3
Shaheed, C. A., Ivers, R. G., Vizza, L., McLachlan, A. J., Kelly, P. J., Blyth, F., Stanaway, F., Clare, P. J., Thompson, R., Lung, T. W.-C., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-075286 · Cited by 3
Self-citationDegenerative spinal disc disease and its treatment
Rossdeutsch, A., Copley, P., & Khan, S. (2017) · Orthopaedics and Trauma · doi:10.1016/j.mporth.2017.09.009 · Cited by 3
HERNIA DEL DISCO INTERVETEBRAL LUMBAR: REVISIÓN NARRATIVA DE CLÍNICA Y MANEJO
Daziano, M. C. (2020) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2020.05.002 · Cited by 3
NAKAJIMA, K., & Fujita, T. (2020) · 日本東洋醫學雜誌 · doi:10.3937/kampomed.71.213 · Cited by 3
McLachlan, H., Maher, C. G., Lin, C. C., Billot, L., Day, R. O., Ivers, R. G., Underwood, M. R., McLachlan, A. J., Richards, B. L., Finnerup, N. B., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-096796 · Cited by 2
Self-citationPlaceboeffekte in wissenschaftlichen Studien
Luomajoki, H. A., & Morf, R. (2020) · Der Schmerzpatient · doi:10.1055/a-1205-5291 · Cited by 2
Mirogabalin for Neuropathic Pain: A Review of Non-Opioid Pharmacotherapy with Insights from Japan
Sumitani, M., Kogure, T., Abe, H., Tsuchida, R., Inoue, R., & Sumitani, M. (2025) · Future Pharmacology · doi:10.3390/futurepharmacol5030031 · Cited by 2
Maintaining Opioid Prescription for Chronic Back Pain: Pro Versus Con
Nagpal, A., Eckmann, M. S., & Weinstein, S. M. (2018) · PM&R · doi:10.1016/j.pmrj.2017.12.002 · Cited by 2
Top studies relevant to primary care practice.
Perry, D., Kolber, M. R., Korownyk, C. S., Lindblad, A. J., Ramji, J., Ton, J., & Allan, G. M. (2018) · Europe PMC (PubMed Central) · Cited by 2
Gabapentinoides: seguridad y uso en el punto de mira
Fuentes, J. V. (2019) · Revista de la Sociedad Española del Dolor · doi:10.20986/resed.2019.3768/2019 · Cited by 2
Anticonvulsants for the Treatment of Low Back Pain and Lumbar Radicular Pain
Gottlieb, M. A., Koyfman, A., & Long, B. (2020) · Academic Emergency Medicine · doi:10.1111/acem.13924 · Cited by 2
Letter to the Editor: Neuropathic pain - definition and drug therapy
Goh, S. L. (2018) · Australian Prescriber · doi:10.18773/austprescr.2018.069 · Cited by 2
Perioperative off-label use of gabapentinoids: evidence-based medicine validated or not?
Savoia, G., & Scibelli, G. (2019) · Minerva Anestesiologica · doi:10.23736/s0375-9393.18.13249-4 · Cited by 2
Jones, C. M. P., Bowden, J. L., Cameron, C. M., Comachio, J., MARCH, L. M., McLachlan, H., & Tiedemann, A. (2024) · Critical Public Health · doi:10.1080/09581596.2024.2439485 · Cited by 2
The Future of Pain Management and Research: A Dose of Fatalism May Be Good for One's Health
Fraser, J. L. (2019) · Pain Medicine · doi:10.1093/pm/pnz047 · Cited by 1
Perioperative Acute Care of Older Patients Living with Frailty
Ke, J. X. C., Macdonald, D. B., & McIsaac, D. I. (2019) · Current anesthesiology reports · doi:10.1007/s40140-019-00355-8 · Cited by 1
“Belief-based” medicine is not evidence-based medicine
Attal, N. (2024) · Pain · doi:10.1097/j.pain.0000000000003281 · Cited by 1
Alkafaji, H., Schmidt, J., Riis, J., Zintchouk, D., & Andersen, S. (2025) · Drugs & Aging · doi:10.1007/s40266-025-01256-8 · Cited by 1
Rückenschmerzen – Prävalenz, Bedeutung und Implikationen für die Prävention und Gesundheitsförderung
Chenot, J. (2021) · Springer Reference Pflege, Therapie, Gesundheit · doi:10.1007/978-3-662-62426-5_49 · Cited by 1
Ducoulombier, V., Challi, H., Petit, P., Leroy, B., Versavel, A., Luraschi, H., Chiquet, R., Zenati, K., Budzik, J., Desrousseaux, J.-F., et al. (2024) · Joint Bone Spine · doi:10.1016/j.jbspin.2024.105797 · Cited by 1
Амелин, А. В., Антипенко, Е. А., Barantsevich, E. R., Барулин, А. Е., Bykov, Y. N., Визило, Т. Л., Давыдов, О. С., Девликамова, Ф. И., Doronina, O. B., Isaeva, N. V., et al. (2025) · Russian Journal of Pain · doi:10.17116/pain20252301184 · Cited by 1
Efficacy and safety of pregabalin in the management of low back pain: a comprehensive meta-analysis
García, C. C., Sánchez‐Raya, J., Rodríguez-Araya, T. L., López-Alarcon, M. D., Trillo‐Calvo, E., Balsalobre, J., & Pérez‐Páramo, M. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1659531 · Cited by 2
Things We Do for No Reason™: Prescribing gabapentinoids for pain
Patel, N. G., Goese, D., Belknap, S. M., Madeira, C. L., & Barsuk, J. H. (2026) · Journal of Hospital Medicine · doi:10.1002/jhm.70286 · Cited by 1
Zheng, Y., Zheng, Y., Chen, P., & Wang, X. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71051 · Cited by 1
Pregabalin bei akuten Ischialgien ineffektiv
Bingel, U. (2017) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-017-0325-8 · Cited by 1
Healthcare expenditure and its predictors in a cohort of Australians living with sciatica
Chye, A., Lin, C. C., Hancock, M. J., Harris, I. A., Latimer, J., Maher, C. G., McLachlan, A. J., Mathieson, S., Koes, B. W., Day, R. O., et al. (2020) · European Spine Journal · doi:10.1007/s00586-020-06605-2 · Cited by 1
Self-citationShetty, S., S., A., Karmakar, A., Mitra, M., Madkholkar, N., Pawar, R., & Sharma, A. (2025) · Cureus · doi:10.7759/cureus.83518 · Cited by 1
Second-Order Peer Reviews of Clinically Relevant Articles for the Physiatrist
Alavinia, M., Furlan, J. C., MacDonald, S. L., & Kumbhare, D. A. (2018) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000000944 · Cited by 1
Spinal pain: causes and treatment policy
Olyunin, Y. A. (2018) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2018-3-53-60 · Cited by 1
Pharmaceutical and Botanical Management of Pain Associated with Psychopathology: A Narrative Review
Hernández-Lozano, M., Sánchez, M. F. O., Rodríguez, R. V. G., Castro-Gerónimo, V. D., Beatriz, L. S. G., Castro‐Torres, I. G., López, M. G. A., Ortiz, J. C. G., Rangel, G. J. M., & Márquez, T. M. C. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91154 · Cited by 1
Management of Neuropathic Pain
Bengtson, K. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-69517-0_37 · Cited by 1
Rückenschmerzen – Prävalenz, Bedeutung und Implikationen für die Prävention und Gesundheitsförderung
Chenot, J. (2019) · Springer Reference Pflege, Therapie, Gesundheit · doi:10.1007/978-3-662-55793-8_49-1 · Cited by 1
Major Concerns Regarding the Conduct of a Trial of Spinal Mobilization for Lumbar Radiculopathy
Zadro, J. R., Traeger, A. C., & Maher, C. G. (2019) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2018.12.025 · Cited by 1
Self-citationPregabalin nicht wirksamer als Placebo in der Behandlung von Ischialgien
Bingel, U. (2017) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-017-2241-y
Ist Pregabalin bei Ischialgien wirksam?
Muheim, L. (2017) · Praxis · doi:10.1024/1661-8157/a002825
Zervikale und lumbale Radikulopathien
Schär, R. T., Pollo, C., Ulrich, C. T., & Raabe, A. (2019) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2019.08296
Pain Management on the Battlefield
Liu, R., Reid, C. O., & Cohen, S. P. (2018) · Springer eBooks · doi:10.1007/978-3-319-95369-4_13
Disc Herniation and Radiculopathy
Earls, B., & Kiefer, M. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-27447-4_12
Organizational and Nursing Issues Related to Spine Pain Care
Arnstein, P. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-27447-4_37
Topiramate and Pregabalin in Lumbar Radicular Pain. Is Topiramate a better option?
Ishfaq, A., Ashraf, J., & Haider, A. (2020) · Journal of Rawalpindi Medical College · doi:10.37939/jrmc.v24i4.1463
Uso de pregabalina en el tratamiento de la ciática
Sguiglia, S. (2019) · Evidencia actualizacion en la práctica ambulatoria · doi:10.51987/evidencia.v21i4.6799
(2017) · Bone and Joint 360 · doi:10.1302/2048-0105.64.360550
Beckett, R. D., Ohiri, A., Johnson, A., & Smith, T. R. (2018) · Side effects of drugs annual · doi:10.1016/bs.seda.2018.07.004
(2017) · Bone and Joint 360 · doi:10.1302/2048-0105.63.360532
Pregabalin No Better Than Placebo in Sciatica
(2017) · Lippincottʼs Bone and Joint Newsletter · doi:10.1097/01.bonej.0000521057.39132.0a
Placebos wirken so gut wie Lyrica©
(2020) · Der Schmerzpatient · doi:10.1055/a-1251-5680
Dott, D. (2022) · Springer eBooks · doi:10.1007/978-3-031-04990-3_8
Verschiedene Optionen für eine medikamentöse Behandlung
Takatalo, J. (2023) · Elsevier eBooks · doi:10.1016/b978-3-437-45252-9.00024-9
(2023) · Elsevier eBooks · doi:10.1016/b978-3-437-45252-9.09976-4
Attal, N., & Bouhassira, D. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780197616345.003.0004
The fight between medicine and scepticism needs to be resolved by evidence: Book reviews
Orchard, J. W. (2023) · JSAMS Plus · doi:10.1016/j.jsampl.2023.100042
Marín‐Medina, D. S., Castaño, J. P., Villada, H. C., Villada-Franco, V., Duque-Salazar, C., Vélez-Monsalve, J. D., Buitrago, D. P. T., Rodríguez, M. C., Montilla, C. A., & Sánchez‐Duque, J. A. (2023) · Revista Peruana de Investigación en Salud · doi:10.35839/repis.7.4.1830
Diagnosi differenziale nel quadro delle lombalgie
Demoulin, C., Tomasella, M., Pesesse, P., Vanderthommen, M., Genevay, S., & Grosdent, S. (2024) · EMC - Medicina Riabilitativa · doi:10.1016/s1283-078x(23)48711-1
Diagnóstico diferencial de las lumbalgias
Demoulin, C., Tomasella, M., Pesesse, P., Vanderthommen, M., Genevay, S., & Grosdent, S. (2024) · EMC - Kinesiterapia - Medicina Física · doi:10.1016/s1293-2965(23)48669-0
The acute lumbosacral radicular syndrome
ter Meulen, B. C. (2024) · doi:10.5463/thesis.591
Recent advances in the pharmacological treatment of chronic pain: a systematic review
Fonseca‐Rodrigues, D., Almeida, A., & Pinto‐Ribeiro, F. (2024) · Revista Dor · doi:10.24875/dor.m24000031
Katz, N. P., Dworkin, R. H., North, R. B., Thomson, S., Eldabe, S. S., Hayek, S. M., Kopell, B. H., Markman, J. D., Rezai, A. R., Taylor, R. S., et al. (2022) · NeuroTarget · doi:10.47924/neurotarget2022124
Gérard, B., Bailly, F., & Trouvin, A. (2024) · Revue du Rhumatisme · doi:10.1016/j.rhum.2024.09.015
Vestibular dysfunction in traumatic brain injury
Rust, H. M., & Seemungal, B. M. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780198834380.003.0029
Gabapentinoids: better at clouding minds than easing backs?
Muggleton, E. (2025) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2025-107166
Metadata
- Authors
- Mathieson, S., Maher, C. G., McLachlan, A. J., Latimer, J., Koes, B. W., Hancock, M. J., Harris, I., Day, R. O., Billot, L., Pik, J., Jan, S., & Lin, C.-W. C.
- Affiliations
- The University of Sydney (AU)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-03-23
- Volume
- 376
- Issue
- 12
- Pages
- 1111-1120
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2600085695
- Cited by
- 219
- References
- 32
- Citations by year
- 2026: 17 · 2025: 15 · 2024: 22 · 2023: 23 · 2022: 16 · 2021: 19 · 2020: 28 · 2019: 30 · 2018: 32 · 2017: 17
- FWCI
- 20.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Funders
- Pfizer
- GlaxoSmithKline
- GlaxoSmithKline Australia
- Medical Research Council
- National Health and Medical Research Council (1042073)
- Topics
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Spine and Intervertebral Disc Pathology
- Keywords
- sciatica, pregabalin, leg pain, neuropathic pain, pain intensity, disability, back pain, quality of life, adverse events, dizziness, drug efficacy, placebo comparison, chronic sciatica, acute sciatica, lumbar radiculopathy, drug safety, dose adjustment, adverse drug reactions
- MeSH terms
- Pregabalin, Adult, Aged, Analgesics, Back Pain, Disability Evaluation, Dizziness, Double-Blind Method, Female, Humans, Male, Middle Aged, Pain Measurement, Quality of Life, Sciatica, Treatment Failure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
